Super V3 Investment Limited Partnership Jafco, 10% Owner at Eleven Biotherapeutics, Inc. (EBIO), sold 6,300 shares at $11.50 ($75K) on 2015-01-26, disclosed to the SEC on 2015-01-26.
Open-market sale of $75k EBIO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.57 | 100 | $1K | 1.5% |
| 2 | $11.70 | 100 | $1K | 1.6% |
| 3 | $11.76 | 100 | $1K | 1.6% |
| 4 | $11.86 | 100 | $1K | 1.6% |
| 5 | $11.87 | 536 | $6K | 8.5% |
| 6 | $11.88 | 100 |
| $1K |
| 1.6% |
| 7 | $11.89 | 300 | $4K | 4.8% |
| 8 | $11.90 | 3,664 | $44K | 58.4% |
| 9 | $11.50 | 200 | $2K | 3.1% |
| 10 | $11.53 | 200 | $2K | 3.1% |
| 11 | $11.68 | 100 | $1K | 1.6% |
| 12 | $11.77 | 100 | $1K | 1.6% |
| 13 | $11.81 | 6 | $71 | 0.1% |
| 14 | $11.82 | 100 | $1K | 1.6% |
| 15 | $11.87 | 100 | $1K | 1.6% |
| 16 | $11.88 | 494 | $6K | 7.9% |
| Total | $11.85 avg | 6,300 | $75K | 100% |
| Filing → |
| TCON | SELL | 2015-10-13 | $32K | — | Filing → |
| TCON | SELL | 2015-10-08 | $221K | — | Filing → |
| TCON | SELL | 2015-10-06 | $152K | — | Filing → |